Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].

Kekkaku : [Tuberculosis] - 1 Jul 2011

Chikamatsu Kinuyo, Mizuno Kazue, Aono Akio, Yamada Hiroyuki, Sugamoto Tetsuhiro, Nishiyama Hiroyuki, Mitarai Satoshi

Abstract excerpt

OBJECTIVE: To evaluate GenoType MTBDRplus (Hain Lifescience, Germany) for its capacity to detect the resistance of rifampicin (RFP) and isoniazid (INH). METHOD: A total of 44 confirmed multi-drug resistant (MDR) and 67 susceptible M. tuberculosis strains were tested for susceptibility to RFP and INH by GenoType MTBDR plus. The core 81bp region of the rpoB gene and the 322bp region of the katG gene and the inhA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antitubercular
Share to Antitubercular Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoniazid

Share to Mycobacterium tuberculosis

Share to Nucleic Acid Amplification Techniques

Share to Nucleic Acid Hybridization

Share to Rifampin

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 21922778

Genes

DST

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].PMID 21922778Read ↗

Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection.Semantic proximity Read ↗

GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples.Semantic proximity Read ↗

[Molecular test Genotype® MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis].Semantic proximity Read ↗

Evaluation of GenoType® MTBDRplus assay for rapid detection of drug susceptibility testing of multi-drug resistance tuberculosis in Northern India.Semantic proximity Read ↗

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.Semantic proximity Read ↗

Evaluation of the GenoType(®) MTBDRplus line probe assay on sputum-positive samples in routine settings in China.Semantic proximity Read ↗

[GenoType MTBDRplus assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis in Sichuan].Semantic proximity Read ↗

Diagnostic Performance of the GenoType MTBDRplus and MTBDRsl Assays to Identify Tuberculosis Drug Resistance in Eastern China.Semantic proximity Read ↗

Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis.Semantic proximity Read ↗

Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis.Semantic proximity Read ↗

Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.Semantic proximity Read ↗

[THE SENSITIVITY AND SPECIFICITY OF THE MOLECULAR GENOTYPE MTBDRPL US ASSAY (HAIN LIFESCIENCE GMBH, GERMANY) FOR RAPID DIAGNOSIS OF DRUG SUSCEPTIBILITY IN MYCOBACTERIUM TUBERCULOSIS ON SPUTUM SPECIMENS].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.